Rocket Lab's Big Rebound? Analysts Suggest the Dip's a Gift

Many investors may have lost patience with Rocket Lab (NASDAQ: RKLB) after the stock tumbled nearly 50% from its 52-week high, but Wall Street hasn’t flinched. Analysts remain as bullish as ever, and despite the sharp correction, the stock never broke below its 200-day SMA. 

It’s also important to remember that this is a stock still up more than 90% year-to-date and over 1000% in the past three years. When a mid-cap space company name posts returns like that, deep pullbacks come with the territory. What matters is that analysts haven’t wavered on the long-term story. In fact, they are leaning in further. The question now is whether investors should share their conviction.

Analyst Targets and Sentiment Push Higher Despite Volatility

The consensus price target has climbed aggressively even as volatility picked up. One year ago, the average target sat at only $16.50. Three months ago, it jumped to $42.27. One month ago, it rose to $51.75. And as of this week, the latest consensus target is $58.17, the highest it has ever been. That steady increase reflects belief in Rocket Lab’s execution and long-range outlook. Throughout the year, the consensus rating has remained a Moderate Buy. Nine of the 15 analysts covering the stock rate it a Buy, five rate it a Hold, and one rates it a Sell.

Momentum from analysts has only strengthened in recent weeks. On Nov. 19, Bank of America raised its target to $60 and reiterated its Buy rating, citing the company’s accelerating launch cadence and growing confidence in Neutron’s debut scheduled for Q1 2026. On Nov. 25, Needham maintained its Buy rating and $63 target price, noting meaningful operational progress, improved Electron reliability, and encouraging financial commentary from CFO Adam Spice regarding Neutron. Shortly after, Cantor Fitzgerald reiterated its Overweight rating, highlighting record revenue and calling the recent weakness a potential buying opportunity ahead of two major catalysts: the Space Development Agency’s Tranche 3 award expected in Q1 2026, and Neutron’s first launch anticipated in Q2 2026.

Even with the slight delay in the Neutron timeline, which many expected, analysts remain confident that Rocket Lab is positioned for substantial growth over the next one to two years.

Operational Execution Holds Steady Across the Business

A significant reason sentiment has stayed resilient is that Rocket Lab’s underlying execution has not faltered. Electron continues to deliver consistent performance, and its growing cadence has further solidified its position as one of the most reliable small-lift rockets in the industry.

At the same time, Rocket Lab’s expanding Space Systems division has become an increasingly important part of the story, giving the company diversified revenue streams and deeper exposure to satellite manufacturing. That operational breadth has always been central to the long-term bull thesis, offering multiple pathways for scale irrespective of launch timing.

Support Has Held, and Catalysts Are Approaching

The recent sell-off may soon begin to give way to price action that better reflects the optimism surrounding the company. The stock found support near the 40 level, which MarketBeat previously highlighted as a key zone. RKLB bounced sharply from that point, reclaimed its 20-day SMA, and stabilized, showing buyers stepped in exactly where they needed to. The higher timeframe structure remains intact, and the stock continues to respect significant support.

With sentiment strong, execution solid, and several meaningful catalysts approaching, Rocket Lab may be entering the early stages of its next move. If Neutron’s debut in early 2026 succeeds and if the SDA contract materializes, shares could reprice quickly as uncertainty fades. These catalysts could not only validate Rocket Lab’s long-term roadmap but also further reinforce its growing role within the rapidly expanding space economy.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

The article "Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift" first appeared on MarketBeat.